Skip to Main Content

Author Details

Francine E Garrett-Bakelman
University of Virginia
1999
48
24
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37131653Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes.bioRxiv2023
37937078Depletion of <i>tet2</i> results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.Front Hematol2023
37407550Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.Blood Cancer J2023
37131653Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes.bioRxiv2023
37502922Multi-ancestry epigenome-wide analyses identify methylated sites associated with aortic augmentation index in TOPMed MESA.Res Sq2023
37502922Multi-ancestry epigenome-wide analyses identify methylated sites associated with aortic augmentation index in TOPMed MESA.Res Sq2023
37937078Depletion of <i>tet2</i> results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.Front Hematol2023
37407550Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.Blood Cancer J2023
35263148Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.Sci Transl Med2022
36151075Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.Blood Cancer J2022
35487785Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.Blood Rev2022
36332294Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling.Leuk Res2022
35119307Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13.Biotechniques2022
35263148Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.Sci Transl Med2022
35487785Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.Blood Rev2022
36332294Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling.Leuk Res2022
36151075Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.Blood Cancer J2022
35119307Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13.Biotechniques2022
34518533DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation.Nat Commun2021
33580203Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia.Leukemia2021
33786584Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias.Blood2021
33567281Clonal hematopoiesis before, during, and after human spaceflight.Cell Rep2021
33500244Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence.Cancer Discov2021
33816475An Esrrb and Nanog Cell Fate Regulatory Module Controlled by Feed Forward Loop Interactions.Front Cell Dev Biol2021
34518533DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation.Nat Commun2021
33567281Clonal hematopoiesis before, during, and after human spaceflight.Cell Rep2021
33786584Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias.Blood2021
33816475An Esrrb and Nanog Cell Fate Regulatory Module Controlled by Feed Forward Loop Interactions.Front Cell Dev Biol2021
33580203Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia.Leukemia2021
33500244Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence.Cancer Discov2021
32894181COCOA: coordinate covariation analysis of epigenetic heterogeneity.Genome Biol2020
33104722Targeted detection and quantitation of histone modifications from 1,000 cells.PLoS One2020
33242411Temporal Telomere and DNA Damage Responses in the Space Radiation Environment.Cell Rep2020
33242410Circulating miRNA Spaceflight Signature Reveals Targets for Countermeasure Development.Cell Rep2020
33242408Multi-omic, Single-Cell, and Biochemical Profiles of Astronauts Guide Pharmacological Strategies for Returning to Gravity.Cell Rep2020
33242405Clonal Hematopoiesis Before, During, and After Human Spaceflight.Cell Rep2020
32894181COCOA: coordinate covariation analysis of epigenetic heterogeneity.Genome Biol2020
33104722Targeted detection and quantitation of histone modifications from 1,000 cells.PLoS One2020
33242411Temporal Telomere and DNA Damage Responses in the Space Radiation Environment.Cell Rep2020
33242410Circulating miRNA Spaceflight Signature Reveals Targets for Countermeasure Development.Cell Rep2020
33242408Multi-omic, Single-Cell, and Biochemical Profiles of Astronauts Guide Pharmacological Strategies for Returning to Gravity.Cell Rep2020
33242405Clonal Hematopoiesis Before, During, and After Human Spaceflight.Cell Rep2020
31076479Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML.Cancer Discov2019
30975860The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight.Science2019
31076479Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML.Cancer Discov2019
31371381CD97 is a critical regulator of acute myeloid leukemia stem cell function.J Exp Med2019
31371381CD97 is a critical regulator of acute myeloid leukemia stem cell function.J Exp Med2019
30975860The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight.Science2019
29275866Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity.Cancer Cell2018
29275866Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity.Cancer Cell2018
  • 1 - 50 of 96

Recommended Authors

Duke University School of Medicine Durham
Career Start Year 2013
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2012
Number of shared co-authors 0
Van Andel Institute
Career Start Year 2010
Number of shared co-authors 2
St. Jude Children's Research Hospital
Career Start Year 2010
Number of shared co-authors 0
Gladstone Institute of Neurological Disease
Career Start Year 2010
Number of shared co-authors 2
Centre Hospitalier Universitaire Sainte-Justine
Career Start Year 2010
Number of shared co-authors 0
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 3
Emory University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
University of California San Diego
Career Start Year 2008
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 6
German Cancer Research Center (DKFZ)
Career Start Year 2006
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2005
Number of shared co-authors 6
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Karolinska Institute
Career Start Year 2003
Number of shared co-authors 2
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 0
St. Jude Children's Research Hospital.
Career Start Year 2001
Number of shared co-authors 2
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 1
Washington University School of Medicine.
Career Start Year 2000
Number of shared co-authors 0
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 1
Roswell Park Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 1
University of British Columbia
Career Start Year 1998
Number of shared co-authors 6
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 6
University of Cambridge
Career Start Year 1996
Number of shared co-authors 4
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 4
The University of Chicago
Career Start Year 1994
Number of shared co-authors 7
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 1
Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra
Career Start Year 1988
Number of shared co-authors 0
German Cancer Research Center
Career Start Year 1982
Number of shared co-authors 4

Collaborators

Co-authored papers 33
Feil Family Brain and Mind Research Institute.
Co-authored papers 19
Co-authored papers 14
Memorial Sloan-Kettering Cancer Center
Co-authored papers 10
Co-authored papers 7
Co-authored papers 5
Co-authored papers 4
NYU Robert I. Grossman School of Medicine
Co-authored papers 3
Co-authored papers 3
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Co-authored papers 3
Adelaide Medical School, University of Adelaide
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Berlin Institute for Medical Systems Biology
Co-authored papers 3
Co-authored papers 3
University of Virginia
Co-authored papers 2
Co-authored papers 2
Boston Children's Hospital
Co-authored papers 2
Meyer Cancer Center
Co-authored papers 2
Johns Hopkins University
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Center for Renal Precision Medicine, University of Texas Health San Antonio
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
The Rockefeller University
Co-authored papers 1
University of Cincinnati College of Medicine
Co-authored papers 1